Rocket Lab Keeps Buy Rating from Cantor Fitzgerald Despite Neutron Delay

At a glance

Rocket Lab's main rocket, Neutron, has been pushed back to 2027, but Cantor Fitzgerald kept a buy rating while lowering its price target. The firm's target still sits about 110% above the current share price.

Key points

1. 1

   Cantor Fitzgerald cut its price target from $122 to $111.

2. 2

   Third-quarter revenue rose 73% to $267.83 million, beating market expectations.

3. 3

   New Neutron contracts worth over $515 million lifted the total backlog to $3.57 billion.

4. 4

   The roughly $8 billion acquisition of Iridium Communications is expected to close in mid-2027.

Why it matters

Rocket Lab is a space launch company, and its results and analyst views are mixed, which matters for anyone weighing an investment decision.